Use

Oncology FISH Analysis – MET Amplification is designed to detect MET gene amplification, which is commonly associated with non-small cell lung cancer (NSCLC). As the most prevalent lung cancer type, NSCLC often exhibits symptoms like coughing and fatigue that may resemble those of less severe conditions. The identification of MET amplification has significant implications as it generally correlates with a poor prognosis. However, it also serves as a predictive marker for responsiveness to targeted MET therapies. Proper interpretation of the test results requires integration with clinical and pathological information; it should not be relied upon solely for diagnosing NSCLC.